These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6437005)

  • 1. Use of porcine factor VIII in the management of seventeen patients with factor VIII antibodies.
    Gatti L; Mannucci PM
    Thromb Haemost; 1984 Jul; 51(3):379-84. PubMed ID: 6437005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of anti-human and anti-porcine factor VIII antibody titers in patients with hemophilia].
    Windyga J; Rzymkiewicz L; Lopaciuk S
    Acta Haematol Pol; 1996; 27(1):27-31. PubMed ID: 8629440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of porcine factor VIII for surgical procedures in hemophilia A patients with inhibitors.
    Lozier JN; Santagostino E; Kasper CK; Teitel JM; Hay CR
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):10-21. PubMed ID: 8480192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse effects of treatment with porcine factor VIII.
    Gringeri A; Santagostino E; Tradati F; Giangrande PL; Mannucci PM
    Thromb Haemost; 1991 Mar; 65(3):245-7. PubMed ID: 1904652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience.
    Brettler DB; Forsberg AD; Levine PH; Aledort LM; Hilgartner MW; Kasper CK; Lusher JM; McMillan C; Roberts H
    Arch Intern Med; 1989 Jun; 149(6):1381-5. PubMed ID: 2499293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disappearance of factor VIII antibodies upon frequent administration of factor VIII.
    Mauser-Bunschoten EP; Roosendaal G; Bruin M; van Dijken PJ
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):533-7. PubMed ID: 1714856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group.
    Kessler CM; Ludlam CA
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):22-7. PubMed ID: 8480193
    [No Abstract]   [Full Text] [Related]  

  • 8. The development and characterisation of antibodies to human factor VIII in haemophilic dogs.
    Littlewood JD; Barrowcliffe TW
    Thromb Haemost; 1987 Jun; 57(3):314-21. PubMed ID: 3116702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
    Klukowska A; Zieleniewska B
    Acta Haematol Pol; 1994; 25(4):349-54. PubMed ID: 7847036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New protocol for immune tolerance induction in acquired hemophilia.
    Nemes L; Pitlik E
    Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with polyelectrolyte-fractionated porcine factor VIII concentrate in the treatment of hemophiliacs with antibodies to factor VIII.
    Kernoff PB; Thomas ND; Lilley PA; Matthews KB; Goldman E; Tuddenham EG
    Blood; 1984 Jan; 63(1):31-41. PubMed ID: 6418234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Poly-electrolyte fractionated porcine factor VIII in the treatment of hemophilia A].
    Ferencz T; Skopál J; Csáki C; Laczkó M; Schuler D; Borsi J
    Orv Hetil; 1993 Dec; 134(52):2873-5. PubMed ID: 8272354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
    Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
    Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of factor VIII inhibitors in non-hemophilic patients.
    Green D
    Prog Clin Biol Res; 1984; 150():337-52. PubMed ID: 6431438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Macrohaematuria post-partum: an unusual case of acquired haemophilia after pregnancy].
    Prencipe MA; D'Errico M; Di Giorgio G; Gatta G; Gesuete A; Nobile M; Stallone C
    G Ital Nefrol; 2002; 19(2):204-8. PubMed ID: 12195420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous appearance of human and porcine factor VIII inhibitors: which therapeutic approach?
    Rossi G; Menchetti D; Morfini M; Filinberti E; Accorsi A; Sassoli S; Caremani M
    Haematologica; 1995; 80(3):244-5. PubMed ID: 7672718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemophilia. Strategies for the treatment of inhibitor patients.
    Ingerslev J
    Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired hemophilia and its treatment.
    Sultan Y
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S15-8. PubMed ID: 9351531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous infusion of porcine factor VIII for the treatment of patients with factor VIII inhibitors.
    Bona RD; Riberio M; Klatsky AU; Panek S; Magnifico M; Rickles FR
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):32-5. PubMed ID: 8480196
    [No Abstract]   [Full Text] [Related]  

  • 20. The importance of corticoids added to continued treatment with Factor VIII concentrates in the suppression of inhibitors in haemophilia A.
    Aznar JA; Jorquera JI; Peiró A; Garcia I
    Thromb Haemost; 1984 Apr; 51(2):217-21. PubMed ID: 6429884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.